Inhibitory effect of BMP-2 on the proliferation of breast cancer cells

Mol Med Rep. 2012 Sep;6(3):615-20. doi: 10.3892/mmr.2012.962. Epub 2012 Jun 21.

Abstract

Bone morphogenetic proteins (BMPs) are involved in diverse biological processes, including cell proliferation, differentiation and apoptosis. Results from the MTT assay revealed that BMP-2 significantly inhibited the proliferation of MDA-MB‑231 and MCF-7 breast cancer cells. The flow cytometric analysis demonstrated that BMP-2 caused G1 arrest and promoted apoptosis. An increase in p21 and cleaved caspase-3 in the two cell lines was detected by western blot analysis, which may be responsible for the suppression of cancer cell proliferation caused by BMP-2. BMP-2 protected MDA-MB-231 and MCF-7 cells from generating xenograft tumors in nude mice. Thus, BMP-2 may be considered as an inhibitor of breast cancer at the early stages of disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis / drug effects
  • Bone Morphogenetic Protein 2 / pharmacology*
  • Bone Morphogenetic Protein 2 / therapeutic use
  • Bone Morphogenetic Protein Receptors, Type I / genetics
  • Bone Morphogenetic Protein Receptors, Type I / metabolism
  • Bone Morphogenetic Protein Receptors, Type II / genetics
  • Bone Morphogenetic Protein Receptors, Type II / metabolism
  • Breast Neoplasms / drug therapy
  • Breast Neoplasms / metabolism
  • Breast Neoplasms / pathology
  • Caspase 3 / metabolism
  • Cell Line, Tumor
  • Cell Proliferation / drug effects*
  • Female
  • G1 Phase Cell Cycle Checkpoints / drug effects
  • Humans
  • Mice
  • Mice, Nude
  • Smad4 Protein / genetics
  • Smad4 Protein / metabolism
  • Transplantation, Heterologous

Substances

  • Bone Morphogenetic Protein 2
  • Smad4 Protein
  • BMPR1A protein, human
  • BMPR1B protein, human
  • BMPR2 protein, human
  • Bone Morphogenetic Protein Receptors, Type I
  • Bone Morphogenetic Protein Receptors, Type II
  • Caspase 3